Bellevue Life Sciences Acquisition (BLAC) Institutional Ownership $1.37 -0.02 (-1.08%) As of 04/29/2025 Add Compare Share Share Ownership Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Bellevue Life Sciences Acquisition (NASDAQ:BLAC)CurrentInstitutional OwnershipPercentage55.30%Number ofInstitutional Buyers(last 12 months)5TotalInstitutional Inflows(last 12 months)$5.54MNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$4.57M Get BLAC Insider Trade Alerts Want to know when executives and insiders are buying or selling Bellevue Life Sciences Acquisition stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BLAC Institutional Buying and Selling by Quarter Bellevue Life Sciences Acquisition Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/15/2024Berkley W R Corp173,901$1.89M0.1%+75.0%4.304% 11/4/2024Wolverine Asset Management LLC267,072$2.91M0.0%-0.7%6.611% 8/16/2024Quarry LP65,000$701K0.2%N/A1.156% 8/14/2024Berkley W R Corp99,358$1.07M0.0%-69.2%1.767% 8/12/2024Clear Street LLC8,592$92K0.0%+6,942.6%0.153% 8/9/2024Warberg Asset Management LLC39,781$429K0.1%+47.1%0.707% 8/7/2024Cowen AND Company LLC193,376$2.08M0.1%-47.7%3.439% 8/2/2024Wolverine Asset Management LLC268,878$2.89M0.0%-7.8%4.784% 5/16/2024Berkley W R Corp322,690$3.44M0.2%N/A5.742% 5/14/2024K2 Principal Fund L.P.33,589$358K0.1%N/A0.598% Get the Latest News and Ratings for BLAC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bellevue Life Sciences Acquisition and its competitors with MarketBeat's FREE daily newsletter. 4/18/2024Wealthspring Capital LLC54,895$585K0.7%-37.3%0.606% 2/13/2024Karpus Management Inc.86,650$910K0.0%-16.1%0.956% 2/12/2024Condor Capital Management11,570$121K0.0%N/A0.128% 2/8/2024Mizuho Securities USA LLC133,495$1.39M0.0%N/A1.473% 2/8/2024Cowen AND Company LLC15,750$165K0.0%N/A0.174% 2/1/2024Wolverine Asset Management LLC183,110$1.92M0.0%+5.8%2.021% 1/17/2024Schechter Investment Advisors LLC211,227$2.22M0.2%+84.1%2.331% 1/16/2024Wealthspring Capital LLC87,579$920K1.2%+335.7%0.967% 11/14/2023AQR Arbitrage LLC449,702$4.68M0.2%+349.7%4.966% 11/14/2023Robinson Capital Management LLC42,000$438K0.2%N/A0.464% 11/13/2023Wolverine Asset Management LLC173,110$1.80M0.0%+40.6%1.911% 11/9/2023Commonwealth of Pennsylvania Public School Empls Retrmt SYS220,723$2.30M0.0%+82.8%2.438% 11/6/2023Schechter Investment Advisors LLC114,711$1.19M0.1%+277.2%1.267% 11/6/2023Periscope Capital Inc.615,652$6.40M0.7%+2,175.8%6.799% 10/23/2023 Deltec Asset Management LLC106,248$1.11M0.3%N/A1.173% 10/23/2023Spartan Fund Management Inc.174,300$1.81M1.4%-12.9%1.924% 10/20/2023Wealthspring Capital LLC20,100$209K0.4%N/A0.222% 8/15/2023Bulldog Investors LLP21,620$222K0.1%-8.6%0.239% 8/14/2023Aristeia Capital LLC165,000$1.69M0.0%+120.0%1.821% 8/14/2023DLD Asset Management LP70,421$723K0.1%N/A0.777% 8/14/2023Kim LLC227,693$2.34M0.2%+66.2%2.513% 8/14/2023Radcliffe Capital Management L.P.150,000$1.54M0.1%N/A1.656% 8/11/2023Karpus Management Inc.103,250$1.06M0.0%+4.0%1.140% 8/10/2023Gabelli Funds LLC29,200$300K0.0%N/A0.322% 8/10/2023GABELLI & Co INVESTMENT ADVISERS INC.20,800$213K0.0%N/A0.230% 8/9/2023Commonwealth of Pennsylvania Public School Empls Retrmt SYS120,723$1.24M0.0%N/A1.332% 8/7/2023Wolverine Asset Management LLC123,110$1.26M0.0%+1.3%1.359% 7/31/2023Spartan Fund Management Inc.200,000$2.05M1.0%N/A2.208% 7/26/2023Spartan Fund Management Inc.57,173$2.05M1.0%N/A0.631% 5/24/2023Mint Tower Capital Management B.V.75,000$758K0.0%N/A0.828% What President Trump’s Executive Order 14154 means for your money (Ad)Nearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a former hedge fund manager who predicted the dotcom crash, the housing crisis, and the 2022 tech stock bloodbath - a little-known executive order from the President's first day in office could spark a paradigm-shift that will likely catch millions of Americans off guard.But because of the massive changes impacting U.S. stocks, Tilson has agreed to publish his latest fi5/12/2023Periscope Capital Inc.27,052$273K0.0%N/A0.299% 5/12/2023Clear Street LLC115,264$1.16M0.0%N/A1.273% 5/11/2023Karpus Management Inc.99,250$1.00M0.0%N/A1.096% 5/11/2023Kim LLC137,000$1.38M0.1%N/A1.513% 5/10/2023Mint Tower Capital Management B.V.225,000$777K0.1%N/A2.483% 5/9/2023Cowen AND Company LLC63,300$639K0.1%N/A0.699% 5/9/2023Mint Tower Capital Management B.V.225,000$1.53M0.1%N/A2.483% 5/8/2023Wolverine Asset Management LLC121,585$1.23M0.0%N/A1.342% 5/5/2023Gritstone Asset Management LLC155,037$1.57M2.0%N/A1.711% (Data available from 1/1/2016 forward) BLAC Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BLAC shares? During the previous two years, 27 institutional investors and hedge funds held shares of Bellevue Life Sciences Acquisition. The most heavily invested institutionals were Periscope Capital Inc. ($6.40M), AQR Arbitrage LLC ($4.68M), Wolverine Asset Management LLC ($2.91M), Kim LLC ($2.34M), Commonwealth of Pennsylvania Public School Empls Retrmt SYS ($2.30M), Schechter Investment Advisors LLC ($2.22M), and Cowen AND Company LLC ($2.08M).Learn more on BLAC's institutional investors. What percentage of Bellevue Life Sciences Acquisition stock is owned by institutional investors? 55.30% of Bellevue Life Sciences Acquisition stock is owned by institutional investors. Learn more on BLAC's institutional investor holdings. Which institutional investors have been buying Bellevue Life Sciences Acquisition stock? Of the 26 institutional investors that purchased Bellevue Life Sciences Acquisition stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Periscope Capital Inc. ($615.65K), Mint Tower Capital Management B.V. ($525K), Berkley W R Corp ($397.23K), AQR Arbitrage LLC ($349.70K), Spartan Fund Management Inc. ($257.17K), Kim LLC ($227.69K), and Commonwealth of Pennsylvania Public School Empls Retrmt SYS ($220.72K). How much institutional buying is happening at Bellevue Life Sciences Acquisition? Institutional investors have bought a total of 4,270,816 shares in the last 24 months. This purchase volume represents approximately $44.12M in transactions. Which Bellevue Life Sciences Acquisition major shareholders have been selling company stock? The following institutional investors have sold Bellevue Life Sciences Acquisition stock in the last 24 months: Berkley W R Corp ($223.33K), Cowen AND Company LLC ($176.48K), Wealthspring Capital LLC ($32.68K), Spartan Fund Management Inc. ($25.70K), Wolverine Asset Management LLC ($24.43K), Karpus Management Inc. ($16.60K), and Bulldog Investors LLP ($2.04K). How much institutional selling is happening at Bellevue Life Sciences Acquisition? Institutional investors have sold a total of 501,269 shares in the last 24 months. This volume of shares sold represents approximately $5.38M in transactions. Related Companies RVP Institutional Ownership NXGL Institutional Ownership NEPH Institutional Ownership IRIX Institutional Ownership QTI Institutional Ownership XAIR Institutional Ownership LFWD Institutional Ownership NRXS Institutional Ownership VVOS Institutional Ownership PSTV Institutional Ownership This page (NASDAQ:BLAC) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bellevue Life Sciences Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bellevue Life Sciences Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BLAC Stock Free BLAC Stock Alerts